Climb Bio annual return on equity
2021
2022
2023
2024
2025
Climb Bio Return on Equity (ROE) Growth & History (CLYM)
Climb Bio's return on equity was −32.15% for fiscal 2025.
View full Climb Bio company overviewClimb Bio annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −32.15% | +14.11 pp |
| 2024 | 2024-12-31 | −46.26% | −16.54 pp |
| 2023 | 2023-12-31 | −29.72% | +0.86 pp |
| 2022 | 2022-12-31 | −30.58% | +36.19 pp |
| 2021 | 2021-12-31 | −66.77% | — |
Climb Bio quarterly return on equity
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −6.96% | −2.39 pp |
| Q1 2026 | 2026-03-31 | −8.89% | +1.36 pp |
| Q4 2025 | 2025-12-31 | −10.38% | −6.47 pp |
| Q3 2025 | 2025-09-30 | −7.11% | −3.07 pp |
| Q2 2025 | 2025-06-30 | −4.57% | +28.83 pp |
| Q1 2025 | 2025-03-31 | −10.26% | −8.67 pp |
| Q4 2024 | 2024-12-31 | −3.91% | −0.56 pp |
| Q3 2024 | 2024-09-30 | −4.03% | −0.46 pp |
| Q2 2024 | 2024-06-30 | −33.40% | −28.85 pp |
| Q1 2024 | 2024-03-31 | −1.59% | +16.57 pp |
| Q4 2023 | 2023-12-31 | −3.35% | +2.55 pp |
| Q3 2023 | 2023-09-30 | −3.57% | +3.43 pp |
| Q2 2023 | 2023-06-30 | −4.55% | +5.26 pp |
| Q1 2023 | 2023-03-31 | −18.15% | −9.96 pp |
| Q4 2022 | 2022-12-31 | −5.90% | +0.23 pp |
| Q3 2022 | 2022-09-30 | −7.00% | +8.28 pp |
| Q2 2022 | 2022-06-30 | −9.82% | — |
| Q1 2022 | 2022-03-31 | −8.19% | — |
| Q4 2021 | 2021-12-31 | −6.13% | — |
| Q3 2021 | 2021-09-30 | −15.28% | — |
Climb Bio return on equity trends
Between the periods ended 2021-12-31 and 2025-12-31, Climb Bio's return on equity increased from −66.77% to −32.15%, a change of +34.62 percentage points. The latest reported quarter, Q2 2026, shows −6.96%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Climb Bio source filings ↗